These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28641926)

  • 1. Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.
    Ifergan I; Davidson TS; Kebir H; Xu D; Palacios-Macapagal D; Cann J; Rodgers JM; Hunter ZN; Pittet CL; Beddow S; Jones CA; Prat A; Sleeman MA; Miller SD
    J Autoimmun; 2017 Nov; 84():1-11. PubMed ID: 28641926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.
    Duncker PC; Stoolman JS; Huber AK; Segal BM
    J Immunol; 2018 Feb; 200(3):966-973. PubMed ID: 29288202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
    Yoshimura S; Thome R; Konno S; Mari ER; Rasouli J; Hwang D; Boehm A; Li Y; Zhang GX; Ciric B; Rostami A
    J Immunol; 2020 Feb; 204(3):531-539. PubMed ID: 31852750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.
    Uyttenhove C; Gaignage M; Donckers D; Nasr Z; Cheou P; van Snick J; D'Auria L; van Pesch V
    Eur J Immunol; 2018 Nov; 48(11):1883-1891. PubMed ID: 30216414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
    McQualter JL; Darwiche R; Ewing C; Onuki M; Kay TW; Hamilton JA; Reid HH; Bernard CC
    J Exp Med; 2001 Oct; 194(7):873-82. PubMed ID: 11581310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity.
    Yang Y; Winger RC; Lee PW; Nuro-Gyina PK; Minc A; Larson M; Liu Y; Pei W; Rieser E; Racke MK; Lovett-Racke AE
    Clin Exp Immunol; 2015 Jan; 179(1):108-18. PubMed ID: 25142403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.
    Croxford AL; Lanzinger M; Hartmann FJ; Schreiner B; Mair F; Pelczar P; Clausen BE; Jung S; Greter M; Becher B
    Immunity; 2015 Sep; 43(3):502-14. PubMed ID: 26341401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis.
    Monaghan KL; Wan ECK
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
    Croxford AL; Spath S; Becher B
    Trends Immunol; 2015 Oct; 36(10):651-662. PubMed ID: 26431942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM-CSF promotes migration of human monocytes across the blood brain barrier.
    Vogel DY; Kooij G; Heijnen PD; Breur M; Peferoen LA; van der Valk P; de Vries HE; Amor S; Dijkstra CD
    Eur J Immunol; 2015 Jun; 45(6):1808-19. PubMed ID: 25756873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
    Guo X; Higgs BW; Bay-Jensen AC; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Rheumatology (Oxford); 2018 Jan; 57(1):175-184. PubMed ID: 29069507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis.
    Ponomarev ED; Shriver LP; Maresz K; Pedras-Vasconcelos J; Verthelyi D; Dittel BN
    J Immunol; 2007 Jan; 178(1):39-48. PubMed ID: 17182538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions.
    Imitola J; Rasouli J; Watanabe F; Mahajan K; Sharan AD; Ciric B; Zhang GX; Rostami A
    J Neuroimmunol; 2018 Apr; 317():45-54. PubMed ID: 29290406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD; McMahon EJ; Schreiner B; Bailey SL
    Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease.
    Pierson ER; Goverman JM
    JCI Insight; 2017 Apr; 2(7):e92362. PubMed ID: 28405624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1β enables CNS access to CCR2
    Paré A; Mailhot B; Lévesque SA; Juzwik C; Ignatius Arokia Doss PM; Lécuyer MA; Prat A; Rangachari M; Fournier A; Lacroix S
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1194-E1203. PubMed ID: 29358392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-related factors as biomarkers in EAE and MS.
    Rumble JM; Huber AK; Krishnamoorthy G; Srinivasan A; Giles DA; Zhang X; Wang L; Segal BM
    J Exp Med; 2015 Jan; 212(1):23-35. PubMed ID: 25559893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE.
    Laurent C; Deblois G; Clénet ML; Carmena Moratalla A; Farzam-Kia N; Girard M; Duquette P; Prat A; Larochelle C; Arbour N
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33323466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.